Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.

Mitchell, Duane A

Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide. [electronic resource] - Cancer immunology research Apr 2015 - 320-5 p. digital

Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

2326-6074

10.1158/2326-6066.CIR-14-0100 doi


Antineoplastic Agents, Alkylating--adverse effects
Autoantibodies--biosynthesis
Cancer Vaccines--adverse effects
Combined Modality Therapy
Dacarbazine--adverse effects
Dendritic Cells--immunology
Glioblastoma--immunology
Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects
Humans
Male
Middle Aged
Temozolomide